IPX203: Clinical Trials

1 trial of IPX203, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow IPX203: new trials by email Literature Review of IPX203 trials Research Report on IPX203

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open Label Extension (OLE) Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease (PD) Participants With Motor Fluctuations
IPX203 - Parkinson Disease
Phase 3CompletedImpax Laboratories, LLC4192019-04-032023-07-13

Conditions studied

Parkinson Disease (1)

Sponsors

Impax Laboratories, LLC (1)

Countries

Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Poland (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

NIH funding

2018 (1)